Cassava Sciences CEO says ‘enormous profit motive’ behind N.Y. law firm’s fraud allegations

Cassava Sciences Inc.'s Chief Executive Remi Barbier repeated on Friday that recent allegations of fraud were "false and misleading" and were a result of investor interests to drive down the price of the biotechnology company's stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.